Research Paper Volume 15, Issue 17 pp 8833—8850
Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer
Figure 8. Prediction of potential chemotherapy drugs. Predicted IC50 values of (A) Z-LLNle-CHO, (B) Sunitinib, (C) S-Trityl-L-cysteine, (D) PHA-665752, (E) Paclitaxel, (F) Dasatinib, (G) CGP-60474, (H) Rapamycin, and (I) Cyclopamine in the ICDRLs risk subtypes.